NorthWest Biotherapeutics Inc (NWBO)

[Gus1212]

Thanks for posting this interview early today.
Yes - Its old but has a tremendous amount of information within, especially for all the new posters/investors reading this board now.

yes - Cannot help myself - purchased more today stock and some options.

http://www.blackandwhiteprogram.com/interview/northwest-biotherapeutics-inc-nwbo-ob-interview-with-linda-f-powers-ceo


This is an interesting paragraph on the cost per patient fro DCVAX.
Again - This interview gives a very good overview of our terrific product.

Here the Paragraph dealing with price of drug, it might have been adjusted since this interview but it gives a good understanding

JE: And the cost effective factor?

LP: Well, with these therapies, the healthcare system would not be paying for a hundred percent of patients to take a drug when only twenty-five percent of them get any effect of it. Secondly, the healthcare system would be getting a lot of bang for their buck with years of extended survival instead of two months of extended survival.

We plan to charge approximately in the range of thirty-seven thousand dollars a year per year of a three year treatment regimen, so about a hundred and ten thousand dollars for all three years combined, and with that we can still produce very nice EBITA (Earnings Before Interest, Taxes and Amortization) margins for our investors. As you know, that’s way below the pricing matrix. I mean Avastin is typically sixty to eighty thousand a year. Even all standbys like Temodar are fifty, sixty thousand a year.

Happy Thanksgiving